LT adjuvant modulates epitope specificity and improves the efficacy of murine antibodies elicited by sublingual vaccination with the N-terminal domain of Streptococcus mutans P1.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Vaccine

• Publication date

  2017-11-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2017.11.007PMID 29146379
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sublingual immunization with the phosphate-binding-protein (PstS) reduces oral colonization by Streptococcus mutans.

  2016cited by this paper
• Global burden of oral diseases: emerging concepts, management and interplay with systemic health.

  2016cited by this paper
• Flagellin-rPAc vaccine inhibits biofilm formation but not proliferation of S. mutans

  2016cited by this paper
• Identification of a Supramolecular Functional Architecture of Streptococcus mutans Adhesin P1 on the Bacterial Cell Surface*

  2015cited by this paper
• Evaluation of mucosal adjuvants and immunization routes for the induction of systemic and mucosal humoral immune responses in macaques

  2015cited by this paper
• Time-Frequency Analysis of Peptide Microarray Data: Application to Brain Cancer Immunosignatures

  2015cited by this paper
• The catalytic A1 domains of cholera toxin and heat-labile enterotoxin are potent DNA adjuvants that evoke mixed Th1/Th17 cellular immune responses

  2015cited by this paper
• Dental caries and vaccination strategy against the major cariogenic pathogen, Streptococcus mutans.

  2014cited by this paper
• The immunosignature of canine lymphoma: characterization and diagnostic application

  2014cited by this paper
• Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses.

  2014cited by this paper
• Gut Adhesive Bacillus subtilis Spores as a Platform for Mucosal Delivery of Antigens

  2014cited by this paper
• Intranasal co-delivery of IL-6 gene enhances the immunogenicity of anti-caries DNA vaccine

  2014cited by this paper
• Immunogenicity and In Vitro and In Vivo Protective Effects of Antibodies Targeting a Recombinant Form of the Streptococcus mutans P1 Surface Protein

  2014cited by this paper
• Buccal and sublingual vaccine delivery

  2014cited by this paper
• Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system

  2014cited by this paper
• An intramolecular lock facilitates folding and stabilizes the tertiary structure of Streptococcus mutans adhesin P1

  2014cited by this paper
• Enhanced Nasal Mucosal Delivery and Immunogenicity of Anti-Caries DNA Vaccine through Incorporation of Anionic Liposomes in Chitosan/DNA Complexes

  2013cited by this paper
• Feasibility of an early Alzheimer's disease immunosignature diagnostic test.

  2013cited by this paper
• Immunosignatures can predict vaccine efficacy

  2013cited by this paper
• Immunosignaturing: a critical review.

  2013cited by this paper
• Intrarectal Immunization and IgA Antibody-Secreting Cell Homing to the Small Intestine

  2013cited by this paper
• The virulence of Streptococcus mutans and the ability to form biofilms

  2013cited by this paper
• Comparative study of classification algorithms for immunosignaturing data

  2012cited by this paper
• MGMR: leveraging RNA-Seq population data to optimize expression estimation

  2012cited by this paper
• Evaluation of Biological Sample Preparation for Immunosignature-Based Diagnostics

  2012cited by this paper
• GuiTope: an application for mapping random-sequence peptides to protein sequences

  2012cited by this paper
• Physical Characterization of the “Immunosignaturing Effect”

  2012cited by this paper
• Sublingual vaccination with fusion protein consisting of the functional domain of hemagglutinin A of Porphyromonas gingivalis and Escherichia coli maltose-binding protein elicits protective immunity in the oral cavity.

  2012cited by this paper
• Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice.

  2011cited by this paper
• Antiviral Activities in Human Saliva

  2011cited by this paper
• Characterization of antigen-presenting cells induced by intragastric immunization with recombinant chimeric immunogens constructed from Streptococcus mutans AgI/II and type I or type II heat-labile enterotoxins.

  2011cited by this paper
• Functional Diversity of Heat-labile Toxins (LT) Produced by Enterotoxigenic Escherichia coli

  2010cited by this paper
• A general method for characterization of humoral immunity induced by a vaccine or infection.

  2010cited by this paper
• Induction of neutralizing antibodies in mice immunized with an amino-terminal polypeptide of Streptococcus mutans P1 protein produced by a recombinant Bacillus subtilis strain.

  2010cited by this paper
• CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein.

  2010cited by this paper
• The changing faces of Streptococcus antigen I/II polypeptide family adhesins

  2010cited by this paper
• Review: Gp-340/DMBT1 in mucosal innate immunity

  2010cited by this paper
• Sublingual Immunization Protects against Helicobacter pylori Infection and Induces T and B Cell Responses in the Stomach

  2010cited by this paper
• Elongated fibrillar structure of a streptococcal adhesin assembled by the high-affinity association of α- and PPII-helices

  2010cited by this paper
• Sublingual vaccination with outer membrane protein of Porphyromonas gingivalis and Flt3 ligand elicits protective immunity in the oral cavity.

  2009cited by this paper
• Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin

  2009cited by this paper
• The effects of IL-6 on CD4 T cell responses.

  2009cited by this paper
• Adjusting batch effects in microarray expression data using empirical Bayes methods.

  2007cited by this paper
• Immune response in humans to a nasal boost with Streptococcus mutans antigens.

  2006cited by this paper
• Immunogenicity of Salmonella vector vaccines expressing SBR of Streptococcus mutans under the control of a T7-nirB (dual) promoter system.

  2006cited by this paper
• Enterotoxin-Based Mucosal Adjuvants Alter Antigen Trafficking and Induce Inflammatory Responses in the Nasal Tract

  2005cited by this paper
• Comparison of the Antibodies in Lymphocyte Supernatant and Antibody-Secreting Cell Assays for Measuring Intestinal Mucosal Immune Response to a Novel Oral Typhoid Vaccine (M01ZH09)

  2005cited by this paper
• Fluid- or Surface-Phase Human Salivary Scavenger Protein gp340 Exposes Different Bacterial Recognition Properties

  2005cited by this paper
• Mucosal Vaccination against Serogroup B Meningococci: Induction of Bactericidal Antibodies and Cellular Immunity following Intranasal Immunization with NadA of Neisseria meningitidis and Mutants of Escherichia coli Heat-Labile Enterotoxin

  2004cited by this paper
• Mucosal immunization against dental caries with plasmid DNA encoding pac gene of Streptococcus mutans in rats.

  2004cited by this paper
• Genome sequence of Streptococcus mutans UA159, a cariogenic dental pathogen

  2002cited by this paper
• Natural Genetic Transformation ofStreptococcus mutans Growing in Biofilms

  2001cited by this paper
• Induction of Protective Immunity againstStreptococcus mutans Colonization after Mucosal Immunization with Attenuated Salmonella enterica Serovar Typhimurium Expressing an S. mutans Adhesin under the Control of In Vivo-Inducible nirB Promoter

  2001cited by this paper
• Cutting Edge: The Mucosal Adjuvant Cholera Toxin Redirects Vaccine Proteins into Olfactory Tissues

  2000cited by this paper
• Comparative Analysis of the Mucosal Adjuvanticity of the Type II Heat-Labile Enterotoxins LT-IIa and LT-IIb

  2000cited by this paper
• Antibody-secreting cells and their relation to humoral antibodies in serum and in nasopharyngeal aspirates in children with pneumococcal acute otitis media.

  1996cited by this paper
• An antigenic peptide inducing cross-reacting antibodies inhibiting the interaction of Streptococcus mutans PAc with human salivary components

  1995cited by this paper
• IgA antibodies to Streptococcus mutans in caries-resistant and -susceptible children.

  1994cited by this paper
• Identification of antigenic epitopes in an alanine-rich repeating region of a surface protein antigen of Streptococcus mutants

  1993cited by this paper
• Immunogenicity and protective effect against oral colonization by Streptococcus mutans of synthetic peptides of a streptococcal surface protein antigen.

  1991cited by this paper
• Surface hydrophobicity, adherence, and aggregation of cell surface protein antigen mutants of Streptococcus mutans serotype c

  1990cited by this paper
• Sequence analysis of the cloned streptococcal cell surface antigen I/II

  1989cited by this paper
• Interaction between surface protein antigens of Streptococcus mutans and human salivary components.

  1989cited by this paper
• Serum and salivary antibodies to Streptococcus mutans in relation to the development and treatment of human dental caries.

  1980cited by this paper
• Wall-associated protein antigens of Streptococcus mutans.

  1979cited by this paper
• Passage of intact IgG from plasma to the oral cavity via crevicular fluid.

  1978cited by this paper
• Characterisation of antigens extracted from cells and culture fluids of Streptococcus mutans serotype c.

  1978cited by this paper

• Cytokines, chemokines, and immune cells involved in oral immunity towards the dental cariogenic bacterium Streptococcus mutans: Therapeutic interventions and vaccination.

  2025cites this paper
• Assessing the Efficacy and Immunogenicity of Anticaries Vaccine—A Systematic Review and Meta‐Analysis

  2025cites this paper
• A new approach in the development of a dental caries vaccine

  2024cites this paper
• The Evolving Microbiome of Dental Caries

  2024cites this paper
• A Nanoparticle-Based Anticaries Vaccine Enhances the Persistent Immune Response To Inhibit Streptococcus mutans and Prevent Caries

  2023cites this paper
• Mucosal Immunization Has Benefits over Traditional Subcutaneous Immunization with Group A Streptococcus Antigens in a Pilot Study in a Mouse Model

  2023influential citation
• Anticaries vaccine as a promising alternative for protection against dental caries: A literature review

  2023cites this paper
• Streptococcus mutans glutamate binding protein (GlnH) as antigen target for a mucosal anti-caries vaccine

  2022cites this paper
• Molecular mechanisms of inhibiting glucosyltransferases for biofilm formation in Streptococcus mutans

  2021cites this paper
• Immunodominance of Epitopes and Protective Efficacy of HI Antigen Are Differentially Altered Using Different Adjuvants in a Mouse Model of Staphylococcus aureus Bacteremia

  2021cites this paper
• Roles of membrane vesicles from Streptococcus mutans for the induction of antibodies to glucosyltransferase in mucosal immunity.

  2020cites this paper
• The Multifaceted Nature of Streptococcal Antigen I/II Proteins in Colonization and Disease Pathogenesis

  2020cites this paper
• The Biology of Streptococcus mutans

  2019cites this paper
• Precision Reengineering of the Oral Microbiome for Caries Management

  2019cites this paper
• Dental caries vaccine: are we there yet?

  2019cites this paper
• Exploiting the Oral Microbiome to Prevent Tooth Decay: Has Evolution Already Provided the Best Tools?

  2019cites this paper